We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.33%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.49B
AUM Growth
+$232M
(+10%)
Cap. Flow
+$288M
Cap. Flow
% of AUM
11.55%
Top 10 Holdings %
Top 10 Hldgs %
7.3%
Holding
1,961
New
637
Increased
441
Reduced
375
Closed
503
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$22.5M |
| 2 |
Electronic Arts
EA
|
+$21.5M |
| 3 |
Five Below
FIVE
|
+$14.6M |
| 4 |
Booking.com
BKNG
|
+$13.7M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$13.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$19.1M |
| 2 |
IBM
IBM
|
+$16.8M |
| 3 |
Adobe
ADBE
|
+$12.2M |
| 4 |
O'Reilly Automotive
ORLY
|
+$11.7M |
| 5 |
US Bancorp
USB
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.39% |
| 2 | Healthcare | 13.08% |
| 3 | Industrials | 12.64% |
| 4 | Financials | 12.15% |
| 5 | Technology | 11.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
676
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $976K | 0.04% |
24,729
-18,900
| -43% | -$735K |
|
|
LEXEA
677
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $975K | 0.04% |
24,836
+12,254
| +97% | +$523K |
|
|
IMGN
678
DELISTED
Immunogen Inc
IMGN
| $972K | 0.04% |
+92,456
| New | +$913K |
|
679
Reinsurance Group of America
RGA
$15.5B
| $970K | 0.04% |
6,300
-21,000
| -77% | -$3.3M |
|
680
Zillow
ZG
$7.85B
| $966K | 0.04% |
17,900
+9,200
| +106% | +$444K |
|
681
Novanta
NOVT
$4.91B
| $960K | 0.04% |
18,414
-23,686
| -56% | -$1.3M |
|
682
The GEO Group
GEO
$4B
| $956K | 0.04% |
46,750
+12,400
| +36% | +$269K |
|
|
ADAP
683
DELISTED
Adaptimmune Therapeutics
ADAP
| $953K | 0.04% |
+84,925
| New | +$743K |
|
|
MCRN
684
DELISTED
Milacron Holdings Corp.
MCRN
| $952K | 0.04% |
+47,303
| New | +$935K |
|
685
Bio-Rad Laboratories Class A
BIO
$8.76B
| $950K | 0.04% |
3,800
+2,000
| +111% | +$509K |
|
686
Fortune Brands Innovations
FBIN
$5.86B
| $950K | 0.04% |
18,888
-26,910
| -59% | -$1.5M |
|
|
PRTK
687
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $950K | 0.04% |
73,137
+56,600
| +342% | +$843K |
|
688
CEVA Inc
CEVA
$831M
| $944K | 0.04% |
26,092
+18,900
| +263% | +$769K |
|
689
CRISPR Therapeutics
CRSP
$4.69B
| $944K | 0.04% |
20,655
-3,800
| -16% | -$157K |
|
690
Old National Bancorp
ONB
$10.2B
| $944K | 0.04% |
55,900
+23,900
| +75% | +$420K |
|
691
Viavi Solutions
VIAV
$7.95B
| $940K | 0.04% |
96,800
-24,400
| -20% | -$232K |
|
692
Wave Life Sciences
WVE
$1.12B
| $937K | 0.04% |
23,379
-2,155
| -8% | -$90.6K |
|
693
Canadian Pacific Kansas City
CP
$81B
| $935K | 0.04% |
26,500
-41,500
| -61% | -$1.5M |
|
694
Perdoceo Education
PRDO
$2.17B
| $934K | 0.04% |
71,148
+51,620
| +264% | +$661K |
|
695
Boise Cascade
BCC
$2.73B
| $931K | 0.04% |
24,130
-72,300
| -75% | -$3M |
|
|
IMPV
696
DELISTED
Imperva, Inc.
IMPV
| $925K | 0.04% |
21,372
+7,300
| +52% | +$328K |
|
697
Kosmos Energy
KOS
$1.47B
| $924K | 0.04% |
+146,723
| New | +$920K |
|
698
Veeva Systems
VEEV
$33.8B
| $924K | 0.04% |
+12,658
| New | +$818K |
|
699
Titan Machinery
TITN
$420M
| $907K | 0.04% |
38,498
-4,600
| -11% | -$96.2K |
|
700
Toro Company
TTC
$8.79B
| $905K | 0.04% |
+14,500
| New | +$924K |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, A.R.T. Advisors held 1,961 positions worth $2.49B, up 10% from $2.26B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
A.R.T. Advisors deployed $288M of net new capital in Q1 2018, opening 637 new positions and adding to 441 existing holdings. Its largest new stake was Ulta Beauty: 104,200 shares worth $21.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was IBM, an estimated $16.8M trimmed.
- A.R.T. Advisors's largest Q1 2018 buy was Ulta Beauty: 104,200 shares worth $21.3M.
- A.R.T. Advisors added most to Five Below in Q1 2018, an estimated $14.6M increase.
- A.R.T. Advisors's biggest Q1 2018 reduction was IBM, cutting an estimated $16.8M.
- A.R.T. Advisors fully exited Netflix in Q1 2018, selling an estimated $19.1M.
- A.R.T. Advisors's ten largest holdings make up 7.3% of its $2.49B portfolio in Q1 2018.
- A.R.T. Advisors opened 637 new positions and closed 503 in Q1 2018.
- A.R.T. Advisors's portfolio value rose 10% quarter-over-quarter to $2.49B.
Based on A.R.T. Advisors's 13F filing for Q1 2018, filed 15 May 2018.